Corcept Therapeutics (CORT) Rockets On FDA Approval; Analyst Sees Peak U.S. Sales of $300M
Go back to Corcept Therapeutics (CORT) Rockets On FDA Approval; Analyst Sees Peak U.S. Sales of $300M| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 120.27 +2.17 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $118.10 | 52 Week High | $10.00 | |||
| Open | $119.37 | 52 Week Low | $3.22 | |||
| Day High | $121.11 | P/E | N/A | |||
| Day Low | $118.37 | EPS | $-0.46 | |||
| Volume | 393,325 | |||||
